Target intelligence / Profile preview

Brain networks associated with mood regulation

Molecular classification
Other
01

Overview

Brain networks associated with mood regulation represent a complex system of integrated neural circuits responsible for the generation, processing, and modulation of emotional states. These networks primarily involve the cortico-limbic circuit, including key nodes such as the prefrontal cortex, amygdala, hippocampus, and anterior cingulate cortex, which coordinate to balance bottom-up emotional triggers with top-down cognitive control [8, 11]. Dysregulation within these networks—characterized by aberrant functional connectivity or impaired neuroplasticity—is a central feature of psychiatric disorders like major depressive disorder and bipolar disorder [3, 7]. Pharmacological treatments, such as SSRIs and ketamine, work by modulating neurotransmitter systems (serotonin, glutamate) to restore healthy network dynamics and promote synaptic growth [15, 19]. Additionally, these networks serve as direct targets for neuromodulation therapies like Transcranial Magnetic Stimulation (TMS), which aim to recalibrate electrical activity in specific cortical regions to alleviate mood symptoms [6, 10]. Understanding these systems is vital for the development of precision medicine approaches that target the specific neural substrates of emotional dysfunction.

Other names
Mood-regulating circuitCortico-limbic networkAffective networkEmotional processing circuitCortico-limbic-striatal circuit
02

Mechanism of action

Drugs modulate neurotransmitter signaling (e.g., serotonin, glutamate) and activate intracellular pathways (e.g., mTOR, BDNF) to enhance synaptic plasticity and normalize functional connectivity between cortical and limbic regions [3, 15].

03

Biological functions

Mood regulationEmotional processingCognitive controlReward processingStress adaptation
04

Disease associations

Major depressive disorderBipolar disorderAnxiety disorderPost-traumatic stress disorder
05

Safety considerations

Manic switch in bipolar patientsSeizure risk (associated with neuromodulation)Network-wide off-target psychiatric effectsSystemic side effects of pharmacological agentsIndividual variability in network architecture limiting treatment efficacy
06

Interacting drugs

Fluoxetine

5 more in the full profile.

07

Biomarkers

fMRI functional connectivityAmygdala reactivityFrontal alpha power (EEG)Hippocampal volumeBrain-derived neurotrophic factor (BDNF) levels

Beyond the preview

Go deeper on Brain networks associated with mood regulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brain networks associated with mood regulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call